What Is Biopeptide EL?
Biopeptide EL is one of the more intriguing compounds currently being explored in dermatological research circles. Also known as Lipopeptide or Palmitoyl Hexapeptide-12, this compound belongs to a class of ingredients known as elastin peptides — short chains of amino acids that appear to interact with the skin’s structural proteins in interesting ways.
At its core, Biopeptide EL contains a six-amino-acid sequence called VGVAPG — the same sequence found naturally in elastin, one of the key proteins responsible for maintaining suppleness and resilience in dermal tissue. Attached to this sequence is a fatty acid component called palmitic acid, which researchers believe may help the peptide reach deeper layers of skin in laboratory models. This combination of properties has made Biopeptide EL one of the more intriguing collagen peptides being studied in modern dermatological research.
How Might Biopeptide EL Interact With Skin Cells?
One of the most interesting things about this elastin peptide is how it appears to behave around a specific type of skin cell called a fibroblast. Fibroblasts are essentially the skin’s structural workforce — they produce collagen, elastin, and other proteins that maintain the skin’s framework in laboratory models.
Early research by Senior et al. found that the VGVAPG sequence in Biopeptide EL may act like a homing signal for fibroblasts, drawing mature, functional cells toward it in a laboratory setting. Interestingly, this effect was only observed in mature fibroblasts capable of producing elastin — not younger, undifferentiated cells — suggesting a fairly specific interaction.
Further research by Kamoun et al. found that when skin fibroblasts were exposed to Biopeptide EL in a lab setting, cell counts roughly doubled compared to untreated controls. The cells also appeared to take on a more elongated shape over time — a structural change associated with active, collagen-producing fibroblasts. Scientists believe this may be linked to the peptide’s interaction with a specific elastin receptor on the surface of fibroblast cells, which may trigger a chain of internal signals associated with cell growth and activity in laboratory settings.
What About Collagen and Elastin?
Here’s where things get particularly interesting for anyone curious about the science of skin firmness. Research by Tajima et al. observed something unexpected: while Biopeptide EL appeared to stimulate fibroblast activity in laboratory models, it also appeared to reduce elastin production at the cellular level — cutting elastin-related genetic activity roughly in half in those same models.
Researchers have suggested this could represent a natural balancing act — as the peptide signals an abundance of elastin, the cells may respond by producing more of other structural proteins, like collagen, instead. The result, in theory, is a shift in the extracellular matrix toward greater structural diversity rather than an overproduction of any single protein. It’s a nuanced finding that underscores why this skin firming peptide continues to attract scientific attention.
Biopeptide EL and Inflammation
Beyond its structural effects, research by Veiga et al. suggests that Biopeptide EL may also play a role in how skin cells respond to stressors like UV exposure in laboratory settings. In cell cultures, the peptide appeared to reduce levels of interleukin-6 (IL-6) — an inflammatory signaling molecule that tends to spike in response to UV light and similar stressors.
Lower IL-6 levels may in turn reduce the activity of enzymes known as matrix metalloproteinases (MMPs), which are associated with the breakdown of the collagen matrix in cellular aging models. In a four-week laboratory evaluation, Biopeptide EL was associated with an approximate 20% improvement in dermal tissue firmness and a 33% improvement in skin tone compared to a placebo — findings that have made this collagen peptide a subject of growing interest in dermatological research.
Biopeptide EL and Skin Pigmentation
One of the more surprising areas of Biopeptide EL research involves its potential interaction with melanocytes — the cells responsible for pigment production in dermal tissue. Research by Chang et al. found that melanocyte precursor cells may carry specific elastin-binding receptors on their surface, and that this elastin peptide may interact with those receptors in notable ways in laboratory settings.
In cell cultures, melanocytes exposed to Biopeptide EL developed more and longer dendrites — the branch-like extensions involved in pigment transfer at a cellular level. The research also found that pigment-containing structures called melanosomes matured more readily following peptide exposure, alongside an increase in the activity of tyrosinase — a key enzyme in the pigment production process. While this research is still in early stages, it opens up interesting questions about how elastin peptides may influence pigmentation processes at a cellular level.
References
- Senior RM, et al. Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes. J Cell Biol. 1984;99(3):870–4.
- Kamoun A, et al. Growth stimulation of human skin fibroblasts by elastin-derived peptides. Cell Adhesion Commun. 1995;3(4):273–281.
- Tajima S, et al. Modulation by elastin peptide VGVAPG of cell proliferation and elastin expression in human skin fibroblasts. Arch Dermatol Res. 1997;289(8):489–492.
- Veiga E, et al. Anti-aging peptides for advanced skincare: focus on nanodelivery systems. J Drug Deliv Sci Technol. 2023;105087.
- Schagen SK. Topical peptide treatments with effective anti-aging results. Cosmetics. 2017;4(2):16.
- Chang CH, et al. Melanocyte precursors express elastin binding protein and elastin-derived peptide (VGVAPG) stimulates their melanogenesis and dendrite formation. J Dermatol Sci. 2008;51(3):158–70.
Disclaimer: The information provided is intended solely for educational and scientific discussion. The compounds described are strictly intended for laboratory research and in-vitro studies only. They are not approved for human or animal consumption, medical use, or diagnostic purposes. Handling is prohibited unless performed by licensed researchers and qualified professionals in controlled laboratory environments.
